Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (891-900 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|August 23, 2011
2nd Charles Richet et Jules Héricourt workshop: therapeutic antibodies and anaphylaxis; May 31-June 1, 2011, Tours, FranceArnaud Daguet, Hervé Watier
Mabs|April 14, 2011
Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical studyNingyan Zhang, Liming Liu, Calin Dan Dumitru, et al.
Mabs|April 14, 2011
The amazing, multipurpose antibodyAlain Beck, Janice M Reichert
Mabs|May 5, 2011
Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T bindingVeysel Kayser, Naresh Chennamsetty, Vladimir Voynov, et al.
Mabs|March 17, 2011
Engineering the variable region of therapeutic IgG antibodiesTomoyuki Igawa, Hiroyuki Tsunoda, Taichi Kuramochi, et al.
Mabs|June 22, 2011
World Antibody Drug Conjugate Summit Europe: February 21-23, 2011; Frankfurt, GermanyAlain Beck, Peter Senter, Ravi Chari
Mabs|June 22, 2011
Immunoglobulin A: A next generation of therapeutic antibodies?Jantine E Bakema, Marjolein van Egmond
Mabs|November 4, 2011
The improvement of an anti-CD22 immunotoxin: conversion to single-chain and disulfide stabilized form and affinity maturation by alanine scanSeiji Kawa, Masanori Onda, Mitchell Ho, et al.
Mabs|November 30, 2011
Generation of scFv phages specific to Staphylococcus enterotoxin C1 by panning on related antigensAnna V Lomonosova, Alexander G Laman, Ksenia K Fursova, et al.
Mabs|November 30, 2011
International intellectual property strategies for therapeutic antibodiesUlrich Storz
Pageof 184

Showing results (891-900 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|August 23, 2011
2nd Charles Richet et Jules Héricourt workshop: therapeutic antibodies and anaphylaxis; May 31-June 1, 2011, Tours, FranceArnaud Daguet, Hervé Watier
Mabs|April 14, 2011
Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical studyNingyan Zhang, Liming Liu, Calin Dan Dumitru, et al.
Mabs|April 14, 2011
The amazing, multipurpose antibodyAlain Beck, Janice M Reichert
Mabs|May 5, 2011
Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T bindingVeysel Kayser, Naresh Chennamsetty, Vladimir Voynov, et al.
Mabs|March 17, 2011
Engineering the variable region of therapeutic IgG antibodiesTomoyuki Igawa, Hiroyuki Tsunoda, Taichi Kuramochi, et al.
Mabs|June 22, 2011
World Antibody Drug Conjugate Summit Europe: February 21-23, 2011; Frankfurt, GermanyAlain Beck, Peter Senter, Ravi Chari
Mabs|June 22, 2011
Immunoglobulin A: A next generation of therapeutic antibodies?Jantine E Bakema, Marjolein van Egmond
Mabs|November 4, 2011
The improvement of an anti-CD22 immunotoxin: conversion to single-chain and disulfide stabilized form and affinity maturation by alanine scanSeiji Kawa, Masanori Onda, Mitchell Ho, et al.
Mabs|November 30, 2011
Generation of scFv phages specific to Staphylococcus enterotoxin C1 by panning on related antigensAnna V Lomonosova, Alexander G Laman, Ksenia K Fursova, et al.
Mabs|November 30, 2011
International intellectual property strategies for therapeutic antibodiesUlrich Storz
Pageof 184